Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 5/2009

01-05-2009 | Hepatobiliary and Pancreatic Tumors

A Marking Technique for Intraoperative Localization of Small Liver Metastases Before Systemic Chemotherapy

Authors: Stéphane Zalinski, MD, Eddie K. Abdalla, MD, Armeen Mahvash, MD, Jean-Nicolas Vauthey, MD

Published in: Annals of Surgical Oncology | Issue 5/2009

Login to get access

Abstract

Preoperative chemotherapy is increasingly used prior to resection of colorectal liver metastases (CLM). Since some of these lesions may disappear or may be hardly detectable with intraoperative ultrasound (IOUS), we describe herein a new technique to mark small lesions with coils before chemotherapy. This technique facilitates the resection of small lesions likely to disappear after preoperative chemotherapy.
Literature
1.
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007–16.PubMedCrossRef
2.
Parikh AA, Gentner B, Wu TT, Curley SA, Ellis LM, Vauthey JN. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg. 2003;7:1082–8.PubMedCrossRef
3.
Adam R, Aloia T, Levi F, Wicherts DA, de Haas RJ, Paule B, et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol. 2007;25:4593–602.PubMedCrossRef
4.
Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg. 2003;7:109–15.PubMedCrossRef
5.
Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004;240:1052–61.PubMedCrossRef
6.
Blazer DG III, Kishi Y, Maru D, Kopetz S, Chun YS, Overman MJ, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008;26:5344–51.PubMedCrossRef
7.
Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer. 2007;110:2761–7.PubMedCrossRef
8.
Benoist S, Brouquet A, Penna C, Julié C, El Hajjam M, Chagnon S, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol. 2006;24:3939–45.PubMedCrossRef
9.
Tan MC, Linehan DC, Hawkins WG, Siegel BA, Strasberg SM. Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response. J Gastrointest Surg. 2007;11:1112–9.PubMedCrossRef
10.
Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–72.PubMedCrossRef
Metadata
Title
A Marking Technique for Intraoperative Localization of Small Liver Metastases Before Systemic Chemotherapy
Authors
Stéphane Zalinski, MD
Eddie K. Abdalla, MD
Armeen Mahvash, MD
Jean-Nicolas Vauthey, MD
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 5/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0328-5

Other articles of this Issue 5/2009

Annals of Surgical Oncology 5/2009 Go to the issue

Breast Oncology

Role of Primary-Site Surgery in Stage IV Breast Cancer

Gastrointestinal Oncology

18F-FDG-PET/CT to Select Patients with Peritoneal Carcinomatosis for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Gastrointestinal Oncology

Neoadjuvant and Postoperative Adjuvant Anticancer Chemotherapy in Gastric Cancer

Breast Oncology

Good Prediction of the Likelihood for Sentinel Lymph Node Metastasis by Using the MSKCC Nomogram in a German Breast Cancer Population

Breast Oncology

Author Reply: Surgery in Stage IV Breast Cancer Patients: Continued Controversy

Breast Oncology

Axillary Staging by Percutaneous Biopsy: Sensitivity of Fine-Needle Aspiration Versus Core Needle Biopsy